NTLA
Intellia Therapeutics, Inc. · Healthcare
President and CEO John M Leonard sold $287K of Intellia Therapeutics, Inc.
Sold$286,819
$12.65Price
22,675Shares
−2%Stake
What NTLA did after the filing
- The stock from Tue, Aug 25 open, $12.84
- −8.8%
- S&P 500, same days
- +1.4%
Measured over 30 trading days, to the Oct 7 close.
Traded Thu, Aug 20. Filed Mon, Aug 24, 4:05 PM ET, after the close. Returns use the Aug 25 open and the Oct 7 close. Not investment advice.